Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by ...
StockStory.org on MSN
Novavax (NVAX) stock trades up, here is why
What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 3% in the morning session after reports ...
The FDA has played an active role in US Health Secretary Robert F. Kennedy Jr.’s agenda to scrutinize vaccines, even if the ...
CDC announces major changes to U.S. childhood vaccine schedule, cutting the number of shots recommended for American children ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback